Combination therapy of cancer with anti-endoglin antibodies and anti-VEGF agents

Details for Australian Patent Application No. 2010284433 (hide)

Owner Tracon Pharmaceuticals, Inc.

Inventors Theuer, Charles P.; Ben K. Seon

Agent Shelston IP

Pub. Number AU-A-2010284433

PCT Pub. Number WO2011/022339

Priority 61/234,574 17.08.09 US

Filing date 16 August 2010

Wipo publication date 24 February 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

15 March 2012 PCT application entered the National Phase

  PCT publication WO2011/022339 Priority application(s): WO2011/022339

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010284437-Attachment of control lines to outside of tubular

2010284428-Use of NKG2D inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes